LifeMD, Inc. cash flow to debt ratio of 130.94% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

LifeMD, Inc.'s free cash flow has decreased 120.72% from $5.98M last year to $-1.24M, signaling decreasing performance

LifeMD, Inc.'s debt to equity ratio is 0.76, which means that the company's assets are unhealthy financed, signaling financial risk.

LifeMD, Inc.'s debt has increased relative to shareholder equity from -4.58 last year to 0.76 today, signaling weakened financials

LifeMD, Inc. has a net cash position, so leverage is healthy.

LifeMD, Inc.'s interest coverage ratio is -72.87, which means that the company struggles to meet interest obligations, signaling financial risk.

LifeMD, Inc.'s profit margin has decreased (16.98%) in the last year from -8.89% to -10.40%, signaling decreasing performance

LifeMD, Inc.'s short-term assets of $51.83M exceed its short-term liabilities of $41.57M

LifeMD, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

LifeMD, Inc.'s return on equity of -179.12%, is lower than 15.00%, indicating bad performance

LifeMD, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

LifeMD, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

LifeMD, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

LifeMD, Inc. has negative free cash flow, indicating cash burn

LifeMD, Inc.'s yearly earnings has increased -62.36% since last year from $-18.88M to $-7.11M, signaling increasing performance

LifeMD, Inc.'s yearly revenue has decreased 8.66% since last year from $212.45M to $194.06M, signaling decreasing performance

ROIC -136.77% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

LifeMD, Inc.'s 3-year revenue CAGR of 17.69% is positive, indicating growing revenue over the past 3 years

LifeMD, Inc. had revenue growth in 4 out of 5 years, indicating consistent revenue performance

LifeMD, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

LifeMD, Inc. has insufficient data to evaluate this check.

LifeMD, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

LifeMD, Inc. is overvalued relative to its fair value price of 0.59 based on EBITDA multiple model

LifeMD, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

LifeMD, Inc. is overvalued relative to its fair value price of -7.90 based on Earnings Fair Value model

LifeMD, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

LifeMD, Inc. has a price-to-book ratio of 21.72x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

LifeMD, Inc. has a price-to-sales ratio of 0.85x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue